Roles of Cofactors in Drug-Induced Liver Injury: Drug Metabolism and Beyond

被引:5
|
作者
Gu, Ruizhi [1 ]
Liang, Alina [2 ]
Liao, Grace [2 ]
To, Isabelle [2 ]
Shehu, Amina [1 ]
Ma, Xiaochao [1 ]
机构
[1] Univ Pittsburgh, Dept Pharmaceut Sci, Ctr Pharmacogenet, Pittsburgh, PA USA
[2] Univ Pittsburgh, Sch Pharm, Pittsburgh, PA USA
基金
美国国家卫生研究院;
关键词
GLUTATHIONE-S-TRANSFERASE; ENDOTHELIAL GROWTH-FACTOR; PREGNANE X RECEPTOR; INDUCED HEPATOTOXICITY; ACETAMINOPHEN HEPATOTOXICITY; OXIDATIVE STRESS; GUT MICROBIOTA; RISK-FACTOR; MODULATES HEPATOTOXICITY; HEPATOCYTE REGENERATION;
D O I
10.1124/dmd.121.000457
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Drug-induced liver injury (DILI) remains one of the major concerns for healthcare providers and patients. Unfortunately, it is difficult to predict and prevent DILI in the clinic because detailed mechanisms of DILI are largely unknown. Many risk factors have been identified for both ???intrinsic??? and ???idiosyncratic??? DILI, suggesting that cofactors are an important aspect in understanding DILI. This review outlines the cofactors that potentiate DILI and categorizes them into two types: (1) the specific cofactors that target metabolic enzymes, transporters, antioxidation defense, immune response, and liver regeneration; and (2) the general cofactors that include inflammation, age, gender, comorbidity, gut microbiota, and lifestyle. The underlying mechanisms by which cofactors potentiate DILI are also discussed. SIGNIFICANCE STATEMENT This review summarizes the risk factors for DILI, which can be used to predict and prevent DILI in the clinic. This work also highlights the gaps in the DILI field and provides future perspectives on the roles of cofactors in DILI.
引用
收藏
页码:646 / 654
页数:9
相关论文
共 50 条
  • [41] Polymorphisms in drug metabolism genes as a risk factor for first-line anti-tuberculosis drug-induced liver injury
    Meitei, Heikrujam Nilkanta
    Pandey, Anupama
    Haobam, Reena
    MOLECULAR BIOLOGY REPORTS, 2023, 50 (03) : 2893 - 2900
  • [42] Drug-Induced Liver Injury in Patients With Chronic Liver Disease
    Ghabril, Marwan
    Vuppalanchi, Raj
    Chalasani, Naga
    LIVER INTERNATIONAL, 2025, 45 (03)
  • [43] Contribution of gut microbiota to drug-induced liver injury
    Chu, Hui-Kuan
    Ai, Yan
    Cheng, Zi-Lu
    Yang, Ling
    Hou, Xiao-Hua
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (05) : 458 - 465
  • [44] Chemical probes for drug-induced liver injury imaging
    Jiang, Tao
    Rong, Pengfei
    Wang, Wei
    FUTURE MEDICINAL CHEMISTRY, 2020, 12 (09) : 835 - 852
  • [45] Novel Clinical Biomarkers for Drug-Induced Liver Injury
    Chen, Youhao
    Guan, Shaoxing
    Guan, Yanping
    Tang, Siyuan
    Zhou, Yanying
    Wang, Xueding
    Bi, Huichang
    Huang, Min
    DRUG METABOLISM AND DISPOSITION, 2022, 50 (05) : 671 - 684
  • [46] Drug-Induced Liver Injury in the Setting of Analgesic Use
    Darr, Umar
    Sussman, Norman Leslie
    CLINICS IN LIVER DISEASE, 2020, 24 (01) : 121 - +
  • [47] Drug-Induced Liver Injury: Mechanisms, Types and Biomarkers
    Vinken, M.
    Maes, M.
    Vanhaecke, T.
    Rogiers, V.
    CURRENT MEDICINAL CHEMISTRY, 2013, 20 (24) : 3011 - 3021
  • [48] Histopathological challenges in suspected drug-induced liver injury
    Kleiner, David E.
    LIVER INTERNATIONAL, 2018, 38 (02) : 198 - 209
  • [49] Current Challenges and Controversies in Drug-Induced Liver Injury
    Corsini, Alberto
    Ganey, Patricia
    Ju, Cynthia
    Kaplowitz, Neil
    Pessayre, Dominique
    Roth, Robert
    Watkins, Paul B.
    Albassam, Mudher
    Liu, Baolian
    Stancic, Saray
    Suter, Laura
    Bortolini, Michele
    DRUG SAFETY, 2012, 35 (12) : 1099 - 1117
  • [50] Genetic and Epigenetic Basis of Drug-Induced Liver Injury
    Singh, Snigdha
    Kumar, P. V. S. N. Kiran
    Kumar, J. Pradeep
    Tomo, Sojit
    Yadav, Dharamveer
    Sharma, Praveen
    Rao, Mahadev
    Banerjee, Mithu
    SEMINARS IN LIVER DISEASE, 2023, 43 (02) : 163 - 175